Search
for
Sort by
Research 211–240 of 1000+
- The Effect of Plasma Rich in Growth Factors on Pattern Hair Loss: A Pilot Study
- Alopecia With Endocrine Therapies in Patients With Cancer
- Gender aspects in skin diseases
- In silico prediction of prostaglandin D2 synthase inhibitors from herbal constituents for the treatment of hair loss
- Clinical applications of antiandrogens
- The Efficacy and Safety of 17α-Estradiol (Ell-Cranell® alpha 0.025%) Solution on Female Pattern Hair Loss: Single Center, Open-Label, Non-Comparative, Phase IV Study
- Finasteride improves motor, EEG, and cellular changes in rat brain in thioacetamide-induced hepatic encephalopathy
- The Effect of Parathyroid Hormones on Hair Follicle Physiology: Implications for Treatment of Chemotherapy-Induced Alopecia
- Drug eruptions in dermatology
- Effect of metformin on clinical and biochemical hyperandrogenism in adolescent girls with type 1 diabetes
- Acne
- Cutaneous drug reactions
- Treatment of acne vulgaris: a literature review / Lečenje običnih akni (acne vulgaris) – pregled literature
- Determinants of Occipital Involvement in Males and Females with Pattern Hair Loss: A Retrospective Study
- Cutaneous Manifestations of Lupus Erythematosus
- Stromal Cells of the Human Postmenopausal Ovary Display a Distinctive Biochemical and Molecular Phenotype
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- Developmental origin of polycystic ovary syndrome - a hypothesis
- The Rotterdam Study: 2018 update on objectives, design and main results
- The cutaneous serotoninergic/melatoninergic system: securing a place under the sun
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- The Rotterdam Study: 2016 objectives and design update
- Air pollution and skin diseases: Adverse effects of airborne particulate matter on various skin diseases
- Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
- Severe cutaneous adverse reactions to drugs
- Genetic, hormonal and metabolic aspects of PCOS: an update
- The North American Menopause Society Recommendations for Clinical Care of Midlife Women
- Development of polycystic ovary syndrome: involvement of genetic and environmental factors
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth